IMVT logo

Immunovant, Inc. Common Stock


IMVT: Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).


Show IMVT Financials

Consumer Interest
SEC Filings

Recent trades of IMVT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by IMVT's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of IMVT in WallStreetBets Daily Discussion


Recent insights relating to IMVT

CNBC Recommendations

Recent picks made for IMVT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IMVT

Corporate Flights

Flights by private jets registered to IMVT